17th Jul 2014 06:35
LONDON (Alliance News) - GlaxoSmithKline PLC faces further scrutiny after it has emerged that its staff were caught bribing Chinese officials more than a decade ago, The Financial Times reported late Wednesday, citing people familiar with the matter.
Glaxo also found problems with its China vaccine business in 2001, which led to the firing of about 30 employees, the report said.
The US Department of Justice, which is investigating the current allegations of bribery at Glaxo, will take a close look at the earlier scandal. Glaxo is currently weathering investigations from Chinese authorities over allegations it paid up to USD500 million to doctors and hospital executives over the past six years.
http://www.ft.com/cms/s/0/d69f494e-0903-11e4-9d3c-00144feab7de.html?siteedition=uk#axzz37XZV3ONO
By Hana Stewart-Smith; [email protected]; @HanaSSAllNews
Copyright 2014 Alliance News Limited. All Rights Reserved.
Related Shares:
Glaxosmithkline